Vitamin D status was not associated with 'one-year' progression of coronary artery disease, assessed by coronary angiography in statin-treated patients

European Journal of Preventive Cardiology

Volumn 22, Issue 5, 2015, Pages 594-602

  Degerud, Eirik ^a   Løland, Kjetil H ^a   Nygård, Ottar ^a,b   Midttun, Øivind ^c   Ueland, Per M ^a,b   Seifert, Reinhard ^b   Strand, Elin ^a   Bleie, Øivind ^b   Dierkes, Jutta ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c BEVITAL AS   (Norway)

Author keywords

25 hydroxyvitamin D; atherosclerosis; calcifediol; coronary angiography; coronary artery disease; disease progression; Vitamin D

Indexed keywords

CALCIFEDIOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; VITAMIN;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE COURSE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STABLE ANGINA PECTORIS; TANDEM MASS SPECTROMETRY; UNSTABLE ANGINA PECTORIS; AGED; BLOOD; CORONARY ANGIOGRAPHY; MIDDLE AGED; PROCEDURES;

AGED; CALCIFEDIOL; CHROMATOGRAPHY, LIQUID; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; TANDEM MASS SPECTROMETRY; VITAMINS;

EID: 84927637678     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487314522137     Document Type: Article

References (40)

1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 ; 380: 2095-2128
2. Murray CJL, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 ; 380: 2197-2223
3. Rose G. Cold weather and ischaemic heart disease. Br J Prev Soc Med. 1966 ; 20: 97-100
4. Hopstock LA, Wilsgaard T, Njolstad I, et al. Seasonal variation in incidence of acute myocardial infarction in a sub-Arctic population: The Tromso Study 1974-2004. Eur J Cardiovasc Prev Rehabil. 2011 ; 18: 320-325
5. Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. Dietary reference intakes: Calcium, vitamin D. Washington, DC: National Academies Press ; 2011: xv, 536, 1115-xv, 536, 1115.
6. Lips P. Vitamin D status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol. 2007 ; 103: 620-625
7. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008 ; 117: 503-511
8. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008 ; 168: 1340-1349
9. Giovannucci E, Liu Y, Hollis BW, et al. 25-hydroxyvitamin D and risk of myocardial infarction in men: A prospective study. Arch Intern Med. 2008 ; 168: 1174-1180
10. Koeffler HP, Amatruda T, Ikekawa N, et al. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. Cancer Res. 1984 ; 44: 5624-5628
11. Merke J, Hofmann W, Goldschmidt D, et al. Demonstration of 1,25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cells in vitro. Calcif Tissue Int. 1987 ; 41: 112-114
12. Merke J, Milde P, Lewicka S, et al. Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest. 1989 ; 83: 1903-1915
13. Mitsuhashi T, Morris RC Jr, Ives HE. 1,25-dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells. J Clin Invest. 1991 ; 87: 1889-1895
14. Kuroki T. Possible functions of 1 alpha,25-dihydroxyvitamin D3, an active form of vitamin D3, in the differentiation and development of skin. J Invest Dermatol. 1985 ; 84: 459-460
15. Welsh J. Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens. Biochem Cell Biol. 1994 ; 72: 537-545
16. Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: Lessons from vitamin D receptor null mice. Endocr Rev. 2008 ; 29: 726-776
17. Ebbing M, Bleie O, Ueland PM, et al. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: A randomized controlled trial. JAMA. 2008 ; 300: 795-804
18. Loland KH, Bleie O, Blix AJ, et al. Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: A Western Norway B Vitamin Intervention Trial (WENBIT) substudy. Am J Cardiol. 2010 ; 105: 1577-1584
19. Løland KH, Bleie Ø, Borgeraas H, et al. The association between progression of atherosclerosis and the methylated amino acids asymmetric dimethylarginine and trimethyllysine. PloS One. 2013 ; 8: e64774-e64774
20. Austen WG, Edwards JE, Frye RL, et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation. 1975 ; 51: 5-40
21. Midttun O, Ueland PM. Determination of vitamins A, D and E in a small volume of human plasma by a high-throughput method based on liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2011 ; 25: 1942-1948
22. Hollis BW. Measuring 25-hydroxyvitamin D in a clinical environment: Challenges and needs. Am J Clin Nutr. 2008 ; 88: 507S-510S
23. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009 ; 150: 604-612
24. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing ; 2008 :
25. Geraci M, Bottai M. Quantile regression for longitudinal data using the asymmetric Laplace distribution. Biostatistics. 2007 ; 8: 140-154
26. Wickham H Ggplot2: Elegant graphics for data analysis. Dordrecht: Springer ; 2009: viii, 212-viii, 212.
27. Duncan A, Talwar D, McMillan DC, et al. Quantitative data on the magnitude of the systemic inflammatory response and its effect on micronutrient status based on plasma measurements. Am J Clin Nutr. 2012 ; 95: 64-71
28. Pittas AG, Chung M, Trikalinos T, et al. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med. 2010 ; 152: 307-314
29. Grandi NC, Breitling LP, Vossen CY, et al. Serum vitamin D and risk of secondary cardiovascular disease events in patients with stable coronary heart disease. Am Heart J. 2010 ; 159: 1044-1051
30. Bittner V, Wenger NK, Waters DD, et al. Vitamin D levels do not predict cardiovascular events in statin-treated patients with stable coronary disease. Am Heart J. 2012 ; 164: 387-393
31. Naesgaard PA, Leon De La Fuente RA, Nilsen ST, et al. Serum 25(OH)D is a 2-year predictor of all-cause mortality, cardiac death and sudden cardiac death in chest pain patients from Northern Argentina. PloS One. 2012 ; 7: e43228-e43228
32. Lim S, Shin H, Kim MJ, et al. Vitamin D inadequacy is associated with significant coronary artery stenosis in a community-based elderly cohort: The Korean Longitudinal Study on Health and Aging. J Clin Endocrinol Metab. 2012 ; 97: 169-178
33. Joergensen C, Reinhard H, Schmedes A, et al. Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rate. Diabetes Care. 2012 ; 35: 168-172
34. Blondon M, Sachs M, Hoofnagle AN, et al. 25-hydroxyvitamin d and parathyroid hormone are not associated with carotid intima-media thickness or plaque in the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol. 2013 ; 33: 2639-2645
35. Deleskog A, Piksasova O, Silveira A, et al. Serum 25-hydroxyvitamin d concentration in subclinical carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 2013 ; 33: 2633-2638
36. Kiani AN, Fang H, Magder LS, et al. Vitamin D deficiency does not predict progression of coronary artery calcium, carotid intima-media thickness or high-sensitivity C-reactive protein in systemic lupus erythematosus. Rheumatology 2013; 52: 2071-2076.
37. Young KA, Snell-Bergeon JK, Naik RG, et al. Vitamin D deficiency and coronary artery calcification in subjects with type 1 diabetes. Diabetes Care. 2011 ; 34: 454-458
38. De Boer IH, Kestenbaum B, Shoben AB, et al. 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol. 2009 ; 20: 1805-1812
39. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011 ; 96: 1911-1930
40. Fiscella K, Franks P. Vitamin D, race, and cardiovascular mortality: Findings from a national US sample. Ann Fam Med. 2010 ; 8: 11-18